Anagrelide hydrochloride is an antiplatelet agent belonging to the imidazoquinazoline class, primarily indicated for the treatment of essential thrombocytosis in patients who have an inadequate response… Read more















Anagrelide hydrochloride is an antiplatelet agent belonging to the imidazoquinazoline class, primarily indicated for the treatment of essential thrombocytosis in patients who have an inadequate response to other therapies. It functions by inhibiting platelet aggregation, which reduces the risk of thrombotic events in individuals with elevated platelet counts. To support rigorous quality control and pharmaceutical research, this category provides high-quality reference standards of the active pharmaceutical ingredient, alongside its related compounds. Laboratories utilize these materials for impurity profiling, method validation, and stability testing, ensuring the safety and efficacy of final drug products. The collection includes pharmacopeial and non-pharmacopeial impurities, degradation products, metabolites, and stable isotope labelled compounds, all essential for accurate analytical characterization and compliance with regulatory standards throughout the drug development lifecycle.